Nurture Genomics, Inc. — Form D
Nurture Genomics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-05. The offering totals $3.0M, of which $355K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-10-05
- Form: D
- Accession: 0001949258-22-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $355K
- Remaining: $2.6M
- Investors: 5
- Date of first sale: 2022-09-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460778
Issuer
- Name: Nurture Genomics, Inc.
- CIK: 0001949258
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: CAMBRIDGE INNOVATION CENTER, 1 BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 6179663216
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Steffanie Bristol | Executive Officer | Cambridge, MA |
| Robert C Green | Director | Cambridge, MA |
| Robert C Green | Executive Officer | Cambridge, MA |
| David C Feinberg | Executive Officer | Cambridge, MA |
| Hans Keil | Director | Cambridge, MA |
| Hans Keil | Executive Officer | Cambridge, MA |
Other filings by this issuer (2)
More